Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujuan Cheng

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Experimental and Therapeutic Medicine|March 26, 2019
Computed tomography coronary angiography vs. standard diagnostic procedure for the diagnosis of angina due to coronary heart disease: A cross-sectional studyZheng Wu, Yi He, Wenzheng Li, et al.
International Journal of Cardiology|January 12, 2022
C-MYC ameliorates ventricular remodeling of myocardial infarction rats via binding to the promoter of microRNA-29a-3p to facilitate TET2 expressionZheng Wu, Shujuan Cheng, Shaoping Wang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 14, 2022
Novel fabrication of bioengineered injectable chitosan hydrogel loaded with conductive nanoparticles to improve therapeutic potential of mesenchymal stem cells in functional recovery after ischemic myocardial infarctionZheng Wu, Wenzheng Li, Shujuan Cheng, et al.
Brain and Behavior|March 2, 2023
Determinants and clinical outcomes of stroke following revascularization among patients with reduced ejection fractionShaoping Wang, Yuhua Ran, Shujuan Cheng, et al.
International Immunopharmacology|February 14, 2021
RETRACTED:BMSCs-derived exosomal microRNA-150-5p attenuates myocardial infarction in miceZheng Wu, Shujuan Cheng, Shaoping Wang, et al.
International Journal of General Medicine|September 20, 2022
Extent of Ejection Fraction Improvement After Revascularization Associated with Outcomes Among Patients with Ischemic Left Ventricular DysfunctionShaoping Wang, Shujuan Cheng, Yuchao Zhang, et al.
International Immunopharmacology|February 23, 2023
Retraction notice to "BMSCs-derived exosomal microRNA-150-5p attenuates myocardial infarction in mice" [Int. Immunopharmacol. 93 (2021) 107389]Zheng Wu, Shujuan Cheng, Shaoping Wang, et al.
Therapeutics and Clinical Risk Management|October 27, 2021
Clinical Outcomes of Patients with Coronary Artery Diseases and Moderate Left Ventricular Dysfunction: Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft SurgeryShaoping Wang, Yi Lyu, Shujuan Cheng, et al.
Frontiers in Pharmacology|March 11, 2020
Pleiotropic Effects of Simvastatin on the Regulation of Potassium Channels in MonocytesShaoping Wang, Yuhua Ran, Xuejun Chen, et al.
International Journal of Biological Sciences|January 22, 2019
Fibroblast Growth Factor 21 Attenuates Vascular Calcification by Alleviating Endoplasmic Reticulum Stress Mediated Apoptosis in RatsYuchen Shi, Shaoping Wang, Hongyu Peng, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Experimental and Therapeutic Medicine|March 26, 2019
Computed tomography coronary angiography vs. standard diagnostic procedure for the diagnosis of angina due to coronary heart disease: A cross-sectional studyZheng Wu, Yi He, Wenzheng Li, et al.
International Journal of Cardiology|January 12, 2022
C-MYC ameliorates ventricular remodeling of myocardial infarction rats via binding to the promoter of microRNA-29a-3p to facilitate TET2 expressionZheng Wu, Shujuan Cheng, Shaoping Wang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 14, 2022
Novel fabrication of bioengineered injectable chitosan hydrogel loaded with conductive nanoparticles to improve therapeutic potential of mesenchymal stem cells in functional recovery after ischemic myocardial infarctionZheng Wu, Wenzheng Li, Shujuan Cheng, et al.
Brain and Behavior|March 2, 2023
Determinants and clinical outcomes of stroke following revascularization among patients with reduced ejection fractionShaoping Wang, Yuhua Ran, Shujuan Cheng, et al.
International Immunopharmacology|February 14, 2021
RETRACTED:BMSCs-derived exosomal microRNA-150-5p attenuates myocardial infarction in miceZheng Wu, Shujuan Cheng, Shaoping Wang, et al.
International Journal of General Medicine|September 20, 2022
Extent of Ejection Fraction Improvement After Revascularization Associated with Outcomes Among Patients with Ischemic Left Ventricular DysfunctionShaoping Wang, Shujuan Cheng, Yuchao Zhang, et al.
International Immunopharmacology|February 23, 2023
Retraction notice to "BMSCs-derived exosomal microRNA-150-5p attenuates myocardial infarction in mice" [Int. Immunopharmacol. 93 (2021) 107389]Zheng Wu, Shujuan Cheng, Shaoping Wang, et al.
Therapeutics and Clinical Risk Management|October 27, 2021
Clinical Outcomes of Patients with Coronary Artery Diseases and Moderate Left Ventricular Dysfunction: Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft SurgeryShaoping Wang, Yi Lyu, Shujuan Cheng, et al.
Frontiers in Pharmacology|March 11, 2020
Pleiotropic Effects of Simvastatin on the Regulation of Potassium Channels in MonocytesShaoping Wang, Yuhua Ran, Xuejun Chen, et al.
International Journal of Biological Sciences|January 22, 2019
Fibroblast Growth Factor 21 Attenuates Vascular Calcification by Alleviating Endoplasmic Reticulum Stress Mediated Apoptosis in RatsYuchen Shi, Shaoping Wang, Hongyu Peng, et al.
Pageof 2